Align Technology, Inc. vs Centrus Energy Corp — how do they compare? Align Technology, Inc. trades at $179.9 (market cap $12.86B), while Centrus Energy Corp trades at $169.54 (market cap $3.37B). The key difference: Align Technology, Inc. is far larger — about 3.8× Centrus Energy Corp's market cap, and Align Technology, Inc. is trading nearer its 52-week high, Centrus Energy Corp nearer its low. Which is the better fit depends on your goals.
| ALGN | LEU | |
|---|---|---|
Market Cap | $12.86B | $3.37B |
Sector | Health | Energy |
52-Week High | $207.19 | $436.00 |
52-Week Low | $124.88 | $146.61 |
Enterprise Value | $11.92B | $2.68B |
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
Centrus Energy (LEU) trades at $171.05, down 1.45% on the day, with a neutral technical outlook. The company recently secured a major Department of Energy contract valued over $1 billion and is set to join the S&P SmallCap 600 index. While Q1 2026 earnings beat expectations, Q4 2025 was a significant miss. Valuation ratios appear elevated with a P/E of 62.2 and P/S of 8.05. Operating cash flow was positive in 2025 but turned negative in 2026 projections.
The outlook is mixed; strong government contracts and index inclusion provide tailwinds, but high valuation and inconsistent earnings pose risks. Analyst consensus is a Buy with a $224.50 price target, suggesting potential upside, though execution on new contracts and profitability trends will be critical for sustained growth.
Trailing returns across standard periods
Latest headlines on both assets
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →Centrus Energy is a leading supplier of nuclear fuel and services for the global power industry. It specializes in supplying low-enriched uranium and developing next-generation fuels for advanced nuclear reactors.
Read more on LEU →